The price of 206 drugs will be reduced! RMB 242 million can be saved

[industry trends of pharmaceutical network] it is reported that Heilongjiang Province will comprehensively implement the results of regional selection (hereinafter referred to as "selected drugs") of pilot drug centralized purchase and use organized by the state as of December 19 According to the purchase data of public hospitals in Heilongjiang Province on the provincial drug centralized purchase platform in 2018, after this adjustment, the total drug cost of the province can be reduced by 242 million yuan, which will greatly reduce the drug cost burden of patients in the province 25 selected drugs, mainly common drugs The 25 selected drugs include cardiovascular system drugs, systemic anti infective drugs, respiratory system drugs, digestive tract drugs and other common drugs, such as ambonol (irbesartan hydrochlorothiazide tablets), Plavix (clopidogrel bisulphate tablets) under Sanofi, as well as neurologic drugs, anti-tumor drugs and other drugs of high concern to patients Price reduction of 206 drugs with specified specifications, a decrease of 27.1% Compared with the lowest purchase price of the alliance region in 2018, the average price of the selected drugs decreased by 59% Only according to the purchase data of the provincial public hospitals on the provincial drug centralized purchase platform in 2018, after the price reduction, the total drug cost of the whole province can be reduced by 242 million yuan, which will greatly reduce the drug cost burden of the patients in the province Corresponding to 25 varieties, a total of 206 drug prices were reduced by 27.1% Three initiatives to implement the implementation plan It is understood that in order to implement the provisions of the implementation plan of centralized drug procurement and use pilot to expand the regional scope, the province also requires the health sector to focus on three tasks First, urge the public medical institutions to purchase and use the selected drugs first, and ensure that the contract amount is completed within one year It is not allowed to influence the reasonable use and supply guarantee of the selected drugs on the grounds of cost control, proportion of drugs and the requirements of drug varieties, specifications and quantities of medical institutions To improve the rational use level of selected drugs, medical institutions should optimize the drug use structure, timely formulate and improve the clinical drug use guidelines of selected drugs, standardize the drug use behavior of doctors, strictly implement the prescription management measures and other relevant diagnosis and treatment specifications, drug use guidelines, and ensure the safety of patients' drug use Second, monitoring and warning of drug shortage information It is required to establish a monitoring system for the use of selected drugs to monitor and analyze the purchase and use of selected drugs and their clinical effects At the same time, it is necessary to strengthen the monitoring of the supply and allocation through the National Health Department's direct reporting system of drug shortage information, and take corresponding measures in time to coordinate and guarantee the supply Third, we should take the centralized purchase and use of drugs as a breakthrough point, summarize the reform experience, enlarge the effect of reform, promote the comprehensive reform of public hospitals as a whole, and better promote the solution of the problem of mass medical treatment It is worth mentioning that many public hospitals have cancelled the drug mark up under the promotion of the medical reform policy of strictly controlling the proportion of drugs The opinions on strengthening the performance appraisal of the three-level public hospitals made it clear that the performance appraisal index system of the three-level public hospitals consists of 55 indexes in four aspects: medical quality, operation efficiency, sustainable development and satisfaction evaluation, and the proportion of drugs no longer used for the appraisal In this regard, the industry believes that the drug proportion policy will be increasingly weakened This time, Heilongjiang Province also made it clear that it should not affect the reasonable use and supply guarantee of the selected drugs on the grounds of cost control, drug proportion and the requirements for drug varieties, specifications and quantities of medical institutions It can be seen that this measure will better benefit the people's livelihood in Heilongjiang Province.